alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.2**
**CERTIFICATION OF CHIEF FINANCIAL OFFICER**
I, Francis G. Meyer, Senior Vice President and Chief Financial Officer, certifythat:
1. I have reviewed this quarterly report of Terra Nitrogen Company, L.P.;
2. Based on my knowledge, this report does not contain any untrue statement ofa material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statements weremade, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrantas of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure thatmaterial information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;
(b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period coveredby this report based on such evaluation; and
(c) Disclosed in this report any change in the registrant’s internal controlover financial reporting that occurred during the registrant’s most recentfiscal quarter (the registrant’s fourth fiscal quarter in the case of an annualreport) that has materially affected, or is reasonably likely to materiallyaffect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based onour most recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonablylikely to adversely affect the registrant’s ability to record, process,summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.   Date: October 31, 2003     /s/ FRANCIS G. MEYER
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Statistical Methods (STATWIs)

Last Modified: 

Print

These documents describe statistical concepts and methods used for various

purposes by the CVB Statistics Section. Inquiries about statistical methods may be

directed to CVB.Data.Help@usda.gov.

Title Doc ID

Publication

Date

Non-parametric Estimation of Median Effective Dose

(1.02 MB) STATWI0001 3/23/2018

Technical Notes for Estimating Diagnostic Sensitivity

and Specificity (779.42 KB) STATWI0002 3/23/2018

Technical Notes for Setting Release Specifications of

Diagnostic Kit Panel Members STATWI0003 withdrawn

Logistic Curve Parameterizations in Commercial

Software (16.27 MB)

CVB-WI0284

2/25/2023

Parallelism Analysis in Assay Validation (690.81 KB) STATWI0006 3/28/2017

Prevented Fraction Methods (774.99 KB) STATWI0007 4/17/2017

Technical Notes Regarding Establishing Control Chart

Parameters (693.58 KB)

CVB-WI5224

1/22/2020
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET OF CNL INCOME FUND XI, LTD. AT SEPTEMBER 30, 1999, AND ITS STATEMENT OF
INCOME FOR THE NINE MONTHS THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO THE FORM 10-Q OF CNL INCOME FUND XI, LTD. FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 1999.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                       1,942,821
<SECURITIES>                                         0
<RECEIVABLES>                                   26,399
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                      24,611,376
<DEPRECIATION>                               2,909,723
<TOTAL-ASSETS>                              35,689,008
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  34,082,050
<TOTAL-LIABILITY-AND-EQUITY>                35,689,008
<SALES>                                              0
<TOTAL-REVENUES>                             2,810,905
<CGS>                                                0
<TOTAL-COSTS>                                  699,349
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              2,249,456
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          2,249,456
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 2,249,456
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0
<FN>
<F1>DUE TO THE NATURE OF ITS INDUSTRY, CNL INCOME FUND XI, LTD. HAS AN
UNCLASSIFIED BALANCE SHEET; THEREFORE, NO VALUES ARE SHOWN ABOVE FOR CURRENT
ASSETS AND CURRENT LIABILITIES.
</FN>




</TABLE>
Establishment: Product Code: Label Type: Pkg Size: 

True Name:

X_____________________________________________________

USDA-APHIS Representative

APHIS USE ONLY

CVB Label #: ML #:

Expires: Total # of Pages 

Replaces Label or Sketch:

Master Label for:

Translation:

Export Only:

Comments:
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED MARCH 22, 2024

NO. 03

- 22

- 00276

- CV

Texas State Library and Archives Commission , Appellant

v.

Corey Westmoreland , Appellee

APPEAL FROM THE 345TH DISTRICT COURT OF TRAVIS COUNTY

B EFOR E CHIEF JUSTICE BYRNE, JUSTICES TRIANA AND SMITH

REVERSED AND RENDERED

-- OPINION BY CHIEF JUSTICE BYRNE

This is an appeal from the order signed by the tr i a l court on April 25, 2 022. Having reviewed the

r ecord and the parties’ arguments, the Court holds that there was reversible error in the court’s

order . Therefore, the Court reverses the trial court’s partial denial of the Commission ’ s plea to

the juris diction as to West morel a nd ’ s counterclaims and render judgme nt granting the plea as to

Westmoreland ’ s remaining counterclaims. The appell ee shall pay all costs relating to this

appeal, both in this Court and in the court below.
#### First Hawaiian Bank v. Cornwall Capital, Inc.

20089

6/22/98

Vacated & Remanded
18741

#### Irvine v. Simon

January 21, 1997

Order No. 97-6

Reversed
Exhibit








EXHIBIT 10.22


[DATE]
[NAME]
[ADDRESS]


Re:  Performance Award 


Dear [NAME],


This letter (the “Letter”) sets forth the amount and terms of a discretionary performance award that you are receiving in recognition of the performance of NIKE, Inc. (the “Company”) for the period [DATE] - [DATE] and your role in delivering such performance.  Effective as of the date hereof, the Company agrees as follows:
		
	1.
	Performance Award.  Subject to the terms and conditions set forth in this Letter, you are hereby awarded a discretionary cash award (the “Award”) of $[AMOUNT].  Your Award will be paid (less applicable taxes required to be withheld with respect to such payment) in [a lump sum] [installments] on [date(s)], subject to your continued employment with the Company through the payment date.  




		
	2.
	Clawback.  The Award is subject to the NIKE, Inc. Policy for Recoupment of Incentive Compensation and any applicable securities, tax and stock exchange laws, rules, regulations and requirements relating to the recoupment or clawback of incentive compensation.  




		
	3.
	No Right to Employment.  For the avoidance of doubt, this Letter does not give you the right to be retained in the employment of the Company or any of its subsidiaries.  The Company reserves the right to terminate you at any time for any reason, notwithstanding the existence of this Letter.




		
	4.
	No Assignment.  Except as otherwise required by applicable law, none of your interests, benefits, payments, claims or rights under this Letter Agreement shall be subject in any manner to any claims of any of your creditors or beneficiaries, nor to alienation by anticipation, sale, transfer, assignment, bankruptcy, pledge, attachment, charge or encumbrance of any kind, and any attempt to take any such action shall be null and void.




		
	5.
	Applicable Law.  This Letter and all rights thereunder shall be governed by and construed in accordance with the laws of the State of Oregon, without giving effect to the conflict of laws principles thereof.




   Sincerely,


	
			
	NIKE, Inc.

	 

	By
	 

	 
	Name:
	 

	 
	Title:
Navigate to Homepage
Search
Main navigation
  

        
              Explore the Capitol Campus
                          Art
                            Buildings & Grounds
                            Capitol Hill Facts
                            Visitor Resources
                            Our Blog
                            What We Do
                          Areas of Expertise
                            Programs & Ceremonies
                            Projects
                            Publications
                            Strategic Objectives
                            About Us
                          Who We Are
                            History of the AOC
                            News & Notices
                            Organizational Structure
                            Partnerships & Recognition
                            Work With UsSearch Search Results
Welcome to search! Use the box below to search across the entire AOC.gov website.
Search
        
                  Content typearticle
  (18)object
  (6)(-)
page
  (1)person
  (1)place
  (6)project
  (1)Displaying 1 - 1 of 1 Clear
            
          Basic pageSummer at the U.S. Capitol|June 20, 2020What can visitors see and do in summer? **Fountains** Although the water features maintained by the Architect of the Capitol (AOC) are not designed for humans to recreate in, several crowd-pleasing pools of cool are located near the U.S. Capitol including the Capitol Reflecting Pool , Senate Park fountain , the Court of Neptune and the U.S Botanic ...What can visitors see and do in summer? Fountains Although the water features maintained by the Architect of the Capitol (AOC) are not designed for humans to recreate in, several crowd-pleasing pools of cool are located near the U.S. Capitol including the Capitol Reflecting Pool , Senate Park Serve. Preserve. Inspire.

              Contact Us
                            Accountability
                            Hill Staff Resources
                            AOC Staff Resources
Utility
  

        
              Privacy Policy
                            Image Terms of Use
                            Inspector General
                            U.S. Botanic Garden
                            U.S. Capitol Visitor CenterFacebook
	Twitter
	Flickr
	YouTube
	Instagram
	Subscribe
<TABLE> <S> <C>

<ARTICLE>               5
<MULTIPLIER>        1,000

<S>                                                                  <C>
<PERIOD-TYPE>                                                               YEAR
<FISCAL-YEAR-END>                                                    DEC-31-1997
<PERIOD-END>                                                         DEC-31-1997
<CASH>                                                                     9,218
<SECURITIES>                                                                  0
<RECEIVABLES>                                                              9,624
<ALLOWANCES>                                                               2,657
<INVENTORY>                                                                    0
<CURRENT-ASSETS>                                                               0
<PP&E>                                                                    11,774
<DEPRECIATION>                                                            11,646
<TOTAL-ASSETS>                                                            27,390
<CURRENT-LIABILITIES>                                                          0
<BONDS>                                                                        0
<PREFERRED-MANDATORY>                                                          0
<PREFERRED>                                                                    0
<COMMON>                                                                       0
<OTHER-SE>                                                                26,174
<TOTAL-LIABILITY-AND-EQUITY>                                              27,390
<SALES>                                                                        0
<TOTAL-REVENUES>                                                           8,454
<CGS>                                                                          0
<TOTAL-COSTS>                                                              3,901
<OTHER-EXPENSES>                                                               0
<LOSS-PROVISION>                                                             455
<INTEREST-EXPENSE>                                                             0
<INCOME-PRETAX>                                                            4,553
<INCOME-TAX>                                                                 (7)
<INCOME-CONTINUING>                                                        4,560
<DISCONTINUED>                                                                 0
<EXTRAORDINARY>                                                                0
<CHANGES>                                                                      0
<NET-INCOME>                                                               4,560
<EPS-PRIMARY>                                                                .61
<EPS-DILUTED>                                                                  0


</TABLE>
ANIMAL CARE AID

Questions? Email us at CenterforAnimalWelfare@usda.gov 

The U.S. Department of Agriculture is an equal opportunity provider, employer, and lender.

Animal Care

Animal and Plant Health Inspection Service 

AC-19-005 • Issued June 2019

Maternal Stress and Puppy Development

Maternal stress in the prenatal period of puppy development can have 

a lifelong impact in the physical and behavioral health of the puppy. 

This Animal Care Aid is part of a series developed to provide information about behavioral development in dogs. 

Refer to the other topics in the series for more information on socialization and the early-rearing environment.

DID YOU KNOW?

A dog’s preference 

for certain smells or 

tastes begins to develop 

before birth. At the time 

of weaning, puppies 

will prefer flavors 

associated with the 

diet fed to their mother 

during pregnancy and 

lactation. Maintaining a 

consistent, high-quality 

diet throughout late 

pregnancy, lactation, 

and weaning will 

decrease maternal 

stress and promote an 

easier transition to solid 

food for puppies.

IT IS IMPORTANT TO AVOID 

OR REDUCE MATERNAL STRESS.

Stress triggers the release of hormones such as 

cortisol into the bloodstream. When these hormones 

cross the placenta from mother to pups, it changes 

the set point of the puppies’ stress response system. 

Stress also alters the quality of maternal care, which 

affects later behavior of the puppies. As adults, these 

puppies are likely to be more fearful and anxious, and 

may to react more strongly to stressful experiences. 

Maternal stress in the prenatal period is associated with:

Psychological 

effects

Physiologic 

effects

Increased risk of:

*pre-term birth 

*low birth weight

*prenatal mortality

*abnormal social and reproductive behavior

*learning problems

*increased anxiety

*insulin resistance, obesity

*impaired immune function

*altered sensitivity and response to pain

HOW CAN I REDUCE MATERNAL STRESS?

l Genetic Selection: Avoid breeding dogs that 

are highly reactive. Temperament traits are 

inherited from both parents, so choose your 

breeding animals wisely. 

l Give frequent, positive human contact. Use 

low-stress handling techniques such as 

stroking, brushing, or offering food treats.

l Provide exercise, such as leash walks or 

time in a play yard, daily.

l Offer daily enrichment. Toys, chew items, music, and 

other sensory stimuli (novel smells or tastes) are a few 

options for mental stimulation and stress relief in dogs.

l Avoid grooming, dental procedures, and preventive care 

such as vaccines during pregnancy. 

l Design whelping and nursery areas to minimize noise 

and social stress from unfamiliar dogs housed nearby.

l Maintain your dog’s housing at a proper temperature 

and humidity level for comfort and good air quality.
EXHIBIT 21

                           SUBSIDIARIES OF REGISTRANT


         The following are the  subsidiaries  of the Company,  for each of which
the voting stock is 100% owned by the Company.

(1)  RSI Holdings of Florida, Inc., incorporated in Florida. This corporation is
     inactive.

(2)  Sunbelt   Distributors,   Inc.,   incorporated  in  South  Carolina.   This
     corporation is inactive.

(3)  Wiegmann & Rose International Corp.,  incorporated in South Carolina.  This
     corporation is inactive.

(4)  HomeAdd Financial Corporation, incorporated in South Carolina.

(5)  HomeAdd  Financial  Services  Corp.,  a wholly owned  subsidiary of HomeAdd
     Financial Corporation, incorporated in North Carolina.
March 5, 2001

22820

#### State v. Quirimit

Affirmed
# C_2016202EN.01013101.xml

| 7.6.2016 | EN | Official Journal of the European Union | C 202/131 |
| --- | --- | --- | --- |

7.6.2016

EN

Official Journal of the European Union

C 202/131

---

Article 185

(ex Article 169 TEC)

(ex Article 169 TEC)

In implementing the multiannual framework programme, the Union may make provision, in agreement with the Member States concerned, for participation in research and development programmes undertaken by several Member States, including participation in the structures created for the execution of those programmes.

---
Exhibit





Exhibit 10.2



AMENDMENT NO. 2 TO THE
KINDER MORGAN, INC.
2015 AMENDED AND RESTATED
STOCK INCENTIVE PLAN
THIS AMENDMENT NO. 2 (the “Amendment”) to the Kinder Morgan, Inc. 2015 Amended and Restated Stock Incentive Plan (the “Plan”) is effective as of July 19, 2017.  Capitalized terms used in this Amendment shall have the same meanings given to them in the Plan unless otherwise indicated.
WHEREAS, the Plan was originally adopted by the Board of Directors (the “Board”) as the Kinder Morgan, Inc. 2011 Stock Incentive Plan, effective as of January 1, 2011. The Plan was amended and restated as the Kinder Morgan, Inc. 2015 Amended and Restated Stock Incentive Plan by the Board on January 21, 2015, and was approved by the Company’s stockholders.  The Plan was amended on January 18, 2017; and
WHEREAS, the Board desires to amend the Plan as set forth herein.
NOW, THEREFORE, the Plan is hereby amended as follows:
1.Amendments.
Section 14 of the Plan shall be deleted in its entirety and replaced with the following: 
“14.    WITHHOLDING OBLIGATIONS. To the extent provided by the terms of an Award Agreement and subject to the discretion of the Committee, the Grantee may satisfy any federal, state, provincial or local tax withholding obligation relating to the exercise or acquisition of Stock under an Award by any of the following means (in addition to the Company’s right to withhold from any compensation paid to the Grantee by the Company) or by a combination of such means:  (a) tendering a cash payment; (b) authorizing the Company to withhold shares of Stock from the shares of Stock otherwise issuable to the Grantee as a result of the exercise or acquisition of Stock under the Award, provided, however, that no shares of Stock are withheld with a value exceeding the maximum statutory tax rates applicable to the Grantee; or (c) delivering to the Company previously owned and unencumbered shares of Stock.”
2.Effect on the Plan.  Other than as specifically set forth herein, all other terms and provisions of the Plan shall remain unaffected by the terms of this Amendment, and shall continue in full force and effect.
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Imports: Veterinary Biological

Products

Last Modified: 

Print

APHIS regulates the import of veterinary biological products, including vaccines,

bacterins, antisera, and diagnostic kits. Our import requirements help ensure that

these products—used to diagnose, prevent, and treat animal diseases in the United

States—are pure, safe, potent, and effective.

You can import international biological products into the United States if you have a

permit for distribution and sale, research and evaluation, or transit shipment. The

regulation guiding this authority is Title 9, Code of Federal Regulations, Part 104.

To apply for an import permit online, follow these steps:

1. Create a USDA eAuthentication account, which you'll need to submit APHIS

Form 2005 online.

2. Submit APHIS Form 2005 through the National Centers for Animal Health

(NCAH) Portal. 

For more information about NCAH, visit the NCAH Portal Guidance page, where you

can find user guides and training videos.
Permits for Distribution and Sale

Products imported under a Permit for Distribution and Sale must meet the same

requirements as domestically produced products. This permit can only be held by

U.S. permittees, which are at least one of the following:

1. A U.S. business

2. An individual residing in the United States

3. An individual operating a business in the United States

With a Permit for Distribution and Sale, you assume legal responsibility for the

imported products. See Veterinary Services Memorandum 800.101 for more

guidance.

Submit Permits for Distribution and Sale applications via the NCAH Portal or

complete APHIS Form 2005 and mail it to: Center for Veterinary Biologics, 1920

Dayton Avenue, P.O. Box 844, Ames, IA 50010.

Submitters will need a "verified identity" USDA eAuthentication account to submit an

application via the NCAH Portal.

Permits for Research and Evaluation or Transit

Shipment

Permits for Research and Evaluation and Permits for Transit Shipment can only be

submitted via the NCAH Portal.

A Permit for Research and Evaluation is valid for 1 year and cannot be renewed. You

need to reapply annually to receive a new permit.

Need Help?

For CVB-related questions, including policy, evaluation, and licensing as well as

inspection and compliance:

Center for Veterinary Biologics
Email: cvb@usda.gov

Phone: 515-337-6100

To report an adverse event:

USDA Adverse Event Reporting

Mailing Address:

1920 Dayton Ave.

P.O. Box 844

Ames, IA 50010

To report an adverse event:

USDA Adverse Event Reporting